GlassScriptPhysician profile
Steven R Kaptik
NPI 1881893345
$4,940.98
in general payments reported to CMS, 2019-2025
15 companies · $3,280 in 2025
The $3,280 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.60 · 2020: $189 · 2021: $111 · 2022: $309 · 2023: $346 · 2024: $668 · 2025: $3,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,813 · Food and Beverage: $1,451 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,812.50 |
| Food and Beverage | $1,451.15 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $1,710.28 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $1,162.50 | 2025 | Imfinzi |
| Medtronic, INC. | $759.92 | 2023-2025 | Gi Genius |
| Boston Scientific Corporation | $379.77 | 2019-2024 | Exalt Model D, Advanix Biliary |
| Fujifilm Healthcare Americas Corporation | $308.88 | 2022 | |
| Janssen Biotech, INC. | $146.48 | 2025 | Tremfya |
| Abbvie INC. | $136.42 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.00 | 2025 | Xifaxan |
| Ambu INC. | $97.45 | 2021 | |
| Pfizer INC. | $30.40 | 2024 | |
| Olympus America INC. | $29.00 | 2025 | |
| Intuitive Surgical, INC. | $21.62 | 2025 | |
| Intercept Pharmaceuticals, INC. | $16.57 | 2024 | |
| Merck Sharp & Dohme LLC | $13.69 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$32,464.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kaptik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.